$HGYN Cashflow Statement | Understand Stock

$HGYN

$0.05 +$0.01 (34.86%) Close

Financial Statements

In USD, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
CASH FLOWS FROM OPERATING ACTIVITIES
Net loss
Net loss
Net Income (loss)
Net (loss) from discontinued operations
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization
Lease expense
Changes in operating assets and liabilities:
Accounts receivable
Inventory
Prepaid expense and other receivable
Accounts payable and accrued liabilities
Deferred revenue
Operating lease payment
Tax payable
Due to related party
Net Cash Provided by Operating Activities from Continuing Operations
Net Cash Used in Operating Activities from Discontinued Operations
Net Cash (Used in) Operating Activities
CASH FLOWS FROM INVESTING ACTIVITIES
Deferred renovation expenses
Development cost of intangible assets
Net Cash (Used in) Investing Activities
CASH FLOWS FROM FINANCING ACTIVITIES
Proceeds from capital contribution
Capital contribution from non-controlling interests
Net Cash Provided by Financing Activities
EFFECT OF EXCHANGE RATE CHANGE ON CASH & CASH EQUIVALENTS
Net change in cash and cash equivalents
Cash and cash equivalents, beginning of period
Cash and cash equivalents, end of period
SUPPLEMENTAL CASH FLOW INFORMATION:
Cash paid for income taxes
NON-CASH INVESTING AND FINANCING ACTIVITIES
Right of use asset and related liability
Acquisitions of subsidiary under common control

Comments